Adherence to tyrosine kinase inhibitors among adult chronic myeloid leukemia patients in a Malaysia hospital

Conclusion The patients in this study demonstrated a relatively deep molecular response and optimal adherence. Nevertheless, one fourth of them were noncompliant with imatinib. Therefore, active interventions are warranted to prevent treatment-associated adverse events and improve adherence.
Source: International Journal of Clinical Pharmacy - Category: Drugs & Pharmacology Source Type: research